Question 1

What is QuilliChew ER?

Accepted Answer

QuilliChew ER is a prescription medication that contains methylphenidate, a central nervous system stimulant. It is commonly associated with the management of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. The medication works by affecting certain chemicals in the brain that contribute to impulse control and hyperactivity. QuilliChew ER is designed to provide extended symptom control throughout the day.

Question 2

What is QuilliChew ER used for?

Accepted Answer

QuilliChew ER is used to treat attention deficit hyperactivity disorder .

Question 3

How does QuilliChew ER work?

Accepted Answer

Mechanism of Action

QuilliChew ER contains methylphenidate, a medication that works by increasing the activity of two specific chemicals in the brain: dopamine and norepinephrine. These chemicals, known as neurotransmitters, play a key role in regulating attention, movement, and motivation.

While the exact way methylphenidate works to treat Attention Deficit Hyperactivity Disorder (ADHD) is not fully understood, it is believed to block the reabsorption of these neurotransmitters back into the brain's nerve cells. By keeping more dopamine and norepinephrine available in the spaces between nerve cells, the medication helps improve communication between different parts of the brain responsible for focus and behavior control.

Extended-Release Technology

QuilliChew ER is designed as an extended-release chewable tablet. This formulation allows the medication to be released into the body in two stages:

Immediate release: A portion of the medication is released shortly after chewing and swallowing to provide early symptom relief.

Extended release: The remaining medication is released gradually throughout the day to maintain consistent levels in the bloodstream.

This delivery system is intended to provide a steady effect, helping to manage ADHD symptoms for a longer duration compared to immediate-release versions of methylphenidate.

Question 4

What are the brand names for QuilliChew ER?

Accepted Answer

QuilliChew ER is sold under the brand names Ritalin , Concerta , and Metadate .

Question 5

What are the active ingredients in QuilliChew ER?

Accepted Answer

The active ingredient in QuilliChew ER is Methylphenidate hydrochloride .

Question 6

What are the side effects of QuilliChew ER?

Accepted Answer

Common side effects of QuilliChew ER may include:

loss of appetite

insomnia

headache

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is QuilliChew ER?

Accepted Answer

QuilliChew ER belongs to the stimulant drug class .

Question 8

What is the dosage of QuilliChew ER and how do I take it?

Accepted Answer

How to Take

QuilliChew ER should be taken by mouth once daily in the morning. The tablet must be chewed thoroughly before swallowing. It can be taken with or without food, but it is helpful to be consistent with how you take it each day.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is already late in the day, skip the missed dose and wait until the next morning to take your regular dose. Taking this medication late in the day may cause difficulty sleeping. Do not take two doses at once to make up for a missed dose.

Question 9

Is QuilliChew ER safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information regarding the safety of using QuilliChew ER during pregnancy. Human data are insufficient to determine a clear risk of birth defects or miscarriage. This medication should only be used during pregnancy if a healthcare provider determines that the potential benefit justifies the potential risk to the fetus.

Healthcare providers may encourage patients who become pregnant while taking QuilliChew ER to enroll in a pregnancy registry. These registries monitor the health of the mother and the baby to collect more information about the safety of ADHD medications during pregnancy.

Breastfeeding

Methylphenidate, the active ingredient in QuilliChew ER, is known to pass into breast milk. The effects of this exposure on a nursing infant are not fully understood. If a mother uses this medication while breastfeeding, the infant should be monitored for potential side effects, such as:

Increased agitation or irritability

Difficulty sleeping

Poor weight gain or feeding issues

Deciding whether to continue breastfeeding while taking QuilliChew ER involves weighing the benefits of breastfeeding against the potential risks of drug exposure to the infant. Patients should consult with their healthcare provider to determine the best course of action.

Question 10

What forms and strengths does QuilliChew ER come in?

Accepted Answer

Dosage Form

QuilliChew ER is available as an extended-release chewable tablet. This formulation is designed to release the active medication gradually over time.

Physical Characteristics

The tablets are scored, which allows them to be broken into pieces along the score lines.

These tablets are specifically intended to be chewed and then swallowed.

Question 11

What is the FDA approval status of QuilliChew ER?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved QuilliChew ER in December 2015. It is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 years of age and older.

Boxed Warning

QuilliChew ER carries a boxed warning, the FDA’s most serious type of warning, regarding the risk of drug abuse and dependence. Healthcare providers are advised to assess the risk of abuse before prescribing and to monitor patients for signs of misuse and dependence during treatment.

Controlled Substance Status

Because it contains methylphenidate, QuilliChew ER is classified as a Schedule II (CII) controlled substance. This classification is used for drugs that have a currently accepted medical use but also a high potential for severe psychological or physical dependence.

Regulatory Requirements

As part of its regulatory status, the FDA requires that a Medication Guide be provided to patients each time the medication is dispensed. This guide outlines important safety information, including potential cardiovascular risks and psychiatric adverse events associated with stimulant medications. The FDA also conducts periodic pediatric safety reviews to monitor the drug's effects in children.

Question 12

What should I know about QuilliChew ER and cost?

Accepted Answer

Insurance Coverage

The out-of-pocket cost for QuilliChew ER is primarily influenced by your health insurance plan. Most plans place medications into different cost tiers; brand-name drugs like QuilliChew ER often fall into higher tiers, which may require a higher co-pay or co-insurance payment than generic alternatives.

Pharmacy Pricing

Retail prices for QuilliChew ER can vary significantly between different pharmacies. Factors such as geographic location and whether you use a local retail pharmacy or a mail-order service can affect the final price. It is often helpful to compare prices at multiple locations.

Generic Availability

QuilliChew ER is a brand-name extended-release chewable tablet. While methylphenidate is available in many generic forms, this specific formulation may not have a direct generic equivalent that is interchangeable at the pharmacy level. Using a brand-name product typically results in higher costs than using generic versions of the same active ingredient.

Financial Assistance

Savings cards and patient assistance programs may be available through the manufacturer to help lower costs for eligible patients. Additionally, some pharmacies and third-party organizations offer discount coupons that can be used by individuals without insurance or those whose insurance does not cover the medication.

QuilliChew ER

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?